Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05828> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05828 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05828 label "LU-31130 [drugbank:DB05828]" assertion.
- drugbank:DB05828 seeAlso DB05828 assertion.
- drugbank:DB05828 description "LU-31130 is a rapid acting therapy developed by H. Lundbeck A/S to treat Psychosis, Schizophrenia and Schizoaffective Disorders. It acts at the Dopamine D4 receptors in the cortex and has low affinity for D2 receptors, adrenoceptors, muscarinic and histaminergic receptors. It provides anti-psychotic characteristic and a low incidence of extrapyramidal and cardiovascular side effects." assertion.
- drugbank:DB05828 identifier "drugbank:DB05828" assertion.
- drugbank:DB05828 title "LU-31130" assertion.
- drugbank:DB05828 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05828 drugbank_vocabulary:drugbank-id "DB05828" assertion.
- drugbank:DB05828 bio2rdf_vocabulary:x-identifiers.org DB05828 assertion.
- drugbank:DB05828 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05828" assertion.
- drugbank:DB05828 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05828 bio2rdf_vocabulary:identifier "DB05828" assertion.